Table 2.
Factors associated with PPR and non-PPR vs. non-readmission after stroke (multinomial logistic regression).
| Table | 30 days | 1 year | ||||||
|---|---|---|---|---|---|---|---|---|
| PPR vs. without readmission | Non-PPR vs. without readmission | PPR vs. without readmission | Non-PPR vs. without readmission | |||||
| OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | |
| Sex | ||||||||
| Female | ||||||||
| Male | 1.05 | (0.98–1.12) | 1.08 | (0.99–1.18) | **1.07 | (1.02–1.13) | ***1.14 | (1.08–1.21) |
| Age | ||||||||
| 18–44 | ||||||||
| 45–64 | **1.29 | (1.09–1.52) | ***0.68 | (0.58–0.80) | **1.20 | (1.07–1.34) | ***0.66 | (0.59–0.74) |
| 65–69 | **1.33 | (1.10–1.60) | ***0.66 | (0.54–0.88) | ***1.39 | (1.22–1.58) | ***0.67 | (0.59–0.77) |
| 70–79 | ***1.43 | (1.20–1.69) | ***0.62 | (0.52–0.74) | ***1.66 | (1.48–1.86) | ***0.71 | (0.64–0.80) |
| ≧ 80 | ***1.61 | (1.35–1.91) | ***0.62 | (0.52–0.74) | ***2.37 | (2.11–2.67) | *0.88 | (0.78–0.99) |
| Monthly income | ||||||||
| 19,048–21,900 | ||||||||
| ≦ 19,047 | 1.07 | (1.00–1.18) | 1.02 | (0.92–1.14) | ***1.11 | (1.04–1.17) | *1.08 | (1.01–1.16) |
| > 21,900 | 1.07 | (0.99–1.17) | 0.99 | (0.89–1.11) | *1.07 | (1.01–1.13) | *1.09 | (1.02–1.18) |
| Year | ||||||||
| 2010 | ||||||||
| 2011 | *0.84 | (0.74–0.97) | 1 | (0.83–1.21) | *0.89 | (0.81–0.98) | 0.96 | (0.85–1.08) |
| 2012 | 0.99 | (0.86–1.13) | 1.07 | (0.88–1.30) | 0.97 | (0.88–1.06) | 0.95 | (0.84–1.07) |
| 2013 | 0.9 | (0.78–1.03) | 1.05 | (0.86–1.27) | 0.92 | (0.84–1.00) | 1.04 | (0.92–1.17) |
| 2014 | 0.95 | (0.83–1.09) | 1.19 | (0.99–1.44) | *0.89 | (0.81–0.98) | 1.06 | (0.94–1.19) |
| 2015 | 0.95 | (0.83–1.09) | **1.31 | (1.09–1.57) | ***0.81 | (0.74–0.90) | 1.06 | (0.94–1.19) |
| 2016 | 1.04 | (0.90–1.19) | ***1.66 | (1.38–2.00) | **0.87 | (0.79–0.96) | ***1.44 | (1.28–1.62) |
| 2017 | 1.07 | (0.93–1.23) | ***1.88 | (1.57–2.26) | ***0.84 | (0.76–0.93) | ***1.52 | (1.35–1.70) |
| 2018 | ***0.99 | (0.85–1.14) | ***1.80 | (1.50–2.16) | ***0.49 | (0.45–0.55) | ***0.85 | (0.75–0.96) |
| Stroke type | ||||||||
| Other type | ||||||||
| ISC | ***1.44 | (1.30–1.60) | 1.06 | (0.94–1.21) | ***1.20 | (1.12–1.28) | 0.93 | (0.86–1.01) |
| ICH | ***1.97 | (1.73–2.25) | **1.29 | (1.10–1.52) | ***1.40 | (1.28–1.53) | 1.08 | (0.97–1.20) |
| SAH | **1.48 | (1.13–1.95) | *1.39 | (1.03–1.87) | 1.17 | (0.97–1.43) | 1.17 | (0.97–1.43) |
| LOS | ***0.97 | (0.97–0.97) | ***0.97 | (0.97–0.97) | ***1.01 | (1.01–1.01) | ***1.01 | (1.01–1.01) |
| CCI | ||||||||
| 0 | ||||||||
| 1–3 | 1.06 | (0.98–1.15) | 1.01 | (0.91–1.12) | ***1.40 | (1.33–1.48) | ***1.28 | (1.19–1.36) |
| 4–6 | ***1.25 | (1.12–1.39) | *1.18 | (1.03–1.36) | ***2.25 | (2.09–2.42) | ***2.15 | (1.97–2.36) |
| ≧ 7 | ***1.75 | (1.48–2.06) | ***2.41 | (1.99–2.90) | ***3.81 | (3.33–4.36) | ***4.94 | (4.27–5.71) |
| SSI | ||||||||
| Mild | ||||||||
| Moderate | ***1.84 | (1.63–2.09) | ***1.98 | (1.68–2.32) | ***1.60 | (1.46–1.75) | ***1.55 | (1.38–1.73) |
| Severe | ***3.69 | (3.34–4.07) | ***4.18 | (3.69–4.74) | ***3.27 | (3.03–3.53) | ***3.18 | (2.90–3.47) |
| Hospital level | ||||||||
| District hospital | ||||||||
| Medical center | 0.96 | (0.88–1.04) | *0.90 | (0.81–1.00) | **1.08 | (1.02–1.14) | **0.92 | (0.86–0.98) |
| Regional hospital | ***1.37 | (1.21–1.54) | *1.22 | (1.04–1.42) | ***1.40 | (1.29–1.53) | *1.12 | (1.00–1.24) |
| Hospital ownership | ||||||||
| Legal person | ||||||||
| Public | *1.11 | (1.02–1.21) | 1.02 | (0.91–1.13) | 1.03 | (0.97–1.10) | 1.04 | (0.96–1.11) |
| Private | *1.12 | (1.01–1.23) | 0.99 | (0.87–1.13) | 1.03 | (0.96–1.11) | 0.98 | (0.90–1.07) |
| Urbanization level | ||||||||
| 1 | ||||||||
| 2 | ***1.38 | (1.24–1.55) | ***1.33 | (1.15–1.53) | **1.13 | (1.05–1.21) | *1.10 | (1.01–1.21) |
| 3 | *1.17 | (1.03–1.33) | 0.98 | (0.83–1.16) | *1.13 | (1.04–1.24) | 1.06 | (0.95–1.18) |
| 4 | ***1.28 | (1.12–1.46) | 1.18 | (0.99–1.40) | **1.15 | (1.05–1.26) | ***1.15 | (1.03–1.28) |
| 5 | ***1.34 | (1.16–1.55) | 1.34 | (1.16–1.55) | **1.24 | (1.12–1.37) | 1.21 | (1.07–1.36) |
*p < 0.05, **p < 0.01, ***p < 0.001.